Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

See mmy (CYSTIC) mummy in the Gene database

Results: 1 to 20 of 29 books (49 items)

1.
Holland-Frei Cancer Medicine. 6th edition.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

2.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2018 Jan-.

3.
Endotext [Internet].

Endotext [Internet].

De Groot LJ, Chrousos G, Dungan K, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

4.
5.
Comparative Oncology.

Comparative Oncology.

Baba AI, Câtoi C.

Bucharest: The Publishing House of the Romanian Academy; 2007.

6.
7.
Diesel and Gasoline Engine Exhausts and Some Nitroarenes.

Diesel and Gasoline Engine Exhausts and Some Nitroarenes.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 2014. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 105.)

8.
9.
Chromium, Nickel and Welding.

Chromium, Nickel and Welding.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 1990. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 49.)

10.
Silica, Some Silicates, Coal Dust and para-Aramid Fibrils.

Silica, Some Silicates, Coal Dust and para-Aramid Fibrils.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 1997. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 68.)

11.
Arsenic, Metals, Fibres and Dusts.

Arsenic, Metals, Fibres and Dusts.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 2012. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100C.)

12.
Suspected Cancer: Recognition and Referral.

Suspected Cancer: Recognition and Referral.

National Collaborating Centre for Cancer (UK).

London: National Institute for Health and Care Excellence (UK); 2015 Jun. (NICE Guideline, No. 12.)

13.
Technology Assessment of Molecular Pathology Testing for the Estimation of Prognosis for Common Cancers [Internet].

Technology Assessment of Molecular Pathology Testing for the Estimation of Prognosis for Common Cancers [Internet].

Meleth S, Reeder-Hayes K, Ashok M, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 May 29.

14.
Trichloroethylene, Tetrachloroethylene, and Some Other Chlorinated Agents.

Trichloroethylene, Tetrachloroethylene, and Some Other Chlorinated Agents.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 2014. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 106.)

15.
Models and Strategies to Integrate Palliative Care Principles into Care for People with Serious Illness: Proceedings of a Workshop.

Models and Strategies to Integrate Palliative Care Principles into Care for People with Serious Illness: Proceedings of a Workshop.

Roundtable on Quality Care for People with Serious Illness; Board on Health Care Services; Board on Health Sciences Policy; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine.

Washington (DC): National Academies Press (US); 2017 Oct 24.

16.
The impact of the National Institute for Health Research Health Technology Assessment programme, 2003–13: a multimethod evaluation.

The impact of the National Institute for Health Research Health Technology Assessment programme, 2003–13: a multimethod evaluation.

Guthrie S, Bienkowska-Gibbs T, Manville C, et al.

Southampton (UK): NIHR Journals Library; 2015 Aug. (Health Technology Assessment, No. 19.67.)

17.
Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene.

Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 2002. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 82.)

18.
Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8.

Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 1997. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 70.)

19.
Man-made Vitreous Fibres.

Man-made Vitreous Fibres.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 2002. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 81.)

20.
Rare Diseases and Orphan Products: Accelerating Research and Development.

Rare Diseases and Orphan Products: Accelerating Research and Development.

Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development; Field MJ, Boat TF, editors.

Washington (DC): National Academies Press (US); 2010.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center